Kevin Patrick Moran - 28 Jul 2023 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, CFO & Treasurer
Signature: /s/ Kevin Patrick Moran
Issuer symbol: VNDA
Transactions as of: 28 Jul 2023
Net transactions value: -$13,945
Form type: 4
Filing time: 01 Aug 2023, 16:30:54 UTC
Previous filing: 20 Jun 2023
Next filing: 21 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	$2,596	-412	-0.34%	$6.30	122,514	28 Jul 2023	Direct	F1
transaction	VNDA	Common Stock	Sale	$11,349	-1,800	-1.5%	$6.30	120,714	28 Jul 2023	Direct	F1
holding	VNDA	Common Stock						635	28 Jul 2023	By Wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Content

Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.